Genomic Valley Biotech Ltd vs Regaal Resources Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 28.43 as of 16 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of Regaal Resources Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of Regaal Resources Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of Regaal Resources Ltd for the Dec '25 is ₹ 323.33 crore as compare to the Sep '25 revenue of ₹ 320.28 crore. This represent the growth of 0.95% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Regaal Resources Ltd for the Dec '25 is ₹ 28.26 crore as compare to the Sep '25 ebitda of ₹ 35.29 crore. This represent the decline of -19.92% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of Regaal Resources Ltd changed from ₹ 9.18 crore to ₹ 13.25 crore over 7 quarters. This represents a CAGR of 23.33% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Regaal Resources Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Regaal Resources Ltd

Regaal Resources Limited was originally incorporated as Regal Resources Private Limited', at Kolkata as a Private Company on January 02, 2012.
Subsequently, the name of the Company was changed to Regaal Resources Private Limited' and a fresh Certificate of Incorporation dated October 26, 2015 was issued by the RoC. Thereafter, the status was converted into a Public Company and the name of the Company was changed to Regaal Resources Limited' and a fresh Certificate of Incorporation dated March 30, 2022 was issued to the Company by RoC. The Company is one of the largest manufacturers of maize based specialty products in India, with an installed crushing capacity of 750 tonnes per day (TPD).
It manufacture native maize starch and modified starch - a plant-based natural starch that is produced from maize; co-products- include gluten, germ, enriched fiber and fiber; and Value added products -food grade starches such as maize flour, icing sugar, custard powder and baking powder.

FAQs for the comparison of Genomic Valley Biotech Ltd and Regaal Resources Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Regaal Resources Ltd?

Market cap of Genomic Valley Biotech Ltd is 8 Cr while Market cap of Regaal Resources Ltd is 837 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Regaal Resources Ltd?

The stock performance of Genomic Valley Biotech Ltd and Regaal Resources Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Regaal Resources Ltd?

As of March 16, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹28.43. On the other hand, Regaal Resources Ltd stock price is INR ₹81.55.

How do dividend payouts of Genomic Valley Biotech Ltd and Regaal Resources Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Regaal Resources Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.